This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Application of gene knockout technology in research of intestinal epithelial barrier mechanism in inflammatory bowel disease
Liu Chen, Huan-Gan Wu, Yin Shi
Liu Chen, Yueyang Clinical Medical School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Huan-Gan Wu, Yin Shi, Shanghai Institute of Acupuncture-Moxibustion and Meridian, Shanghai 200030, China
Supported by: National Natural Science Foundation of China, Nos. 81273844 and 81473757; National Basic Research Program of China (973 Program), No. 2015CB554500.
Correspondence to: Yin Shi, Chief Physician, Shanghai Institute of Acupuncture-Moxibustion and Meridian, 630 Wanping South Road, Shanghai 200030, China. flysy0636@163.com
Received: August 6, 2015 Revised: August 21, 2015 Accepted: September 7, 2015 Published online: October 18, 2015
Intestinal epithelial barrier permeability changes/increase caused by intestinal epithelial barrier damage play an important role in the pathogenesis of inflammatory bowel disease, and the maintenance of normal intestinal epithelial barrier permeability depends on the two aspects of the trans-epithelial cell pathway and the tight connection between the cells. In recent years, with the development of molecular biology technology and wide application of a variety of gene engineering technology, specific knocking out a particular gene through gene knockout technology to study the pathogenesis of the disease has become a hot research topic. In this paper, we review the application of gene knockout technology in the research of intestinal epithelial barrier trans-epithelial pathway and tight junction pathway in inflammatory bowel disease, in order to provide some ideas for further study of the pathogenesis of inflammatory bowel disease.
Citation: Chen L, Wu HG, Shi Y. Application of gene knockout technology in research of intestinal epithelial barrier mechanism in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(29): 4673-4679
Cui Z, Wang H, Tan Y, Zaia KA, Zhang S, Tsien JZ. Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain.Neuron. 2004;41:781-793.
[PubMed] [DOI]
Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application.Am J Pathol. 2006;169:1901-1909.
[PubMed] [DOI]
Fukumoto K, Naito Y, Takagi T, Yamada S, Horie R, Inoue K, Harusato A, Hirata I, Omatsu T, Mizushima K. Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice.Int J Mol Med. 2011;27:353-359.
[PubMed] [DOI]
Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.Trends Immunol. 2009;30:383-391.
[PubMed] [DOI]
Vereecke L, Sze M, Mc Guire C, Rogiers B, Chu Y, Schmidt-Supprian M, Pasparakis M, Beyaert R, van Loo G. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.J Exp Med. 2010;207:1513-1523.
[PubMed] [DOI]
Gordon M, El-Kalla M, Zhao Y, Fiteih Y, Law J, Volodko N, Anwar-Mohamed A, El-Kadi AO, Liu L, Odenbach J. The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury.PLoS One. 2013;8:e75483.
[PubMed] [DOI]
Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.Oncogene. 2008;27:2128-2136.
[PubMed] [DOI]
Shi C, Liang Y, Yang J, Xia Y, Chen H, Han H, Yang Y, Wu W, Gao R, Qin H. MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury.PLoS One. 2013;8:e66814.
[PubMed] [DOI]
Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.Cancer Cell. 2009;15:103-113.
[PubMed] [DOI]
Han X, Osuntokun B, Benight N, Loesch K, Frank SJ, Denson LA. Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.Am J Pathol. 2006;169:1999-2013.
[PubMed] [DOI]
Han X, Ren X, Jurickova I, Groschwitz K, Pasternak BA, Xu H, Wilson TA, Hogan SP, Denson LA. Regulation of intestinal barrier function by signal transducer and activator of transcription 5b.Gut. 2009;58:49-58.
[PubMed] [DOI]
Brechter AB, Persson E, Lundgren I, Lerner UH. Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases.Bone. 2008;43:72-83.
[PubMed] [DOI]
McEachern AE, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, Fujisaki J, Aldrich RW, Jarnagin K. Expression cloning of a rat B2 bradykinin receptor.Proc Natl Acad Sci U S A. 1991;88:7724-7728.
[PubMed] [DOI]
Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes.Br J Pharmacol. 2004;143:803-818.
[PubMed] [DOI]
Liu LB, Xue YX, Liu YH, Wang YB. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.J Neurosci Res. 2008;86:1153-1168.
[PubMed] [DOI]
Danese S, Vetrano S, Zhang L, Poplis VA, Castellino FJ. The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.Blood. 2010;115:1121-1130.
[PubMed] [DOI]
Vetrano S, Ploplis VA, Sala E, Sandoval-Cooper M, Donahue DL, Correale C, Arena V, Spinelli A, Repici A, Malesci A. Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation.Proc Natl Acad Sci U S A. 2011;108:19830-19835.
[PubMed] [DOI]
Garçon L, Rivat C, James C, Lacout C, Camara-Clayette V, Ugo V, Lecluse Y, Bennaceur-Griscelli A, Vainchenker W. Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells.Blood. 2006;108:1551-1554.
[PubMed] [DOI]
Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.Cell. 2004;118:229-241.
[PubMed] [DOI]
Zhou W, Cao Q, Peng Y, Zhang QJ, Castrillon DH, DePinho RA, Liu ZP. FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation.Gastroenterology. 2009;137:1403-1414.
[PubMed] [DOI]
Martìn-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration.J Cell Biol. 1998;142:117-127.
[PubMed] [DOI]
Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, Babbin BA, Williams IR, Koval M, Peatman E, Campbell JA. JAM-A regulates permeability and inflammation in the intestine in vivo.J Exp Med. 2007;204:3067-3076.
[PubMed] [DOI]
Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor.Ann Intern Med. 1986;105:883-885.
[PubMed] [DOI]
Miehsler W, Püspök A, Oberhuber T, Vogelsang H. Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.Inflamm Bowel Dis. 2001;7:99-105.
[PubMed] [DOI]
Vavricka SR, Rogler G. New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options?Swiss Med Wkly. 2009;139:527-534.
[PubMed] [DOI]
Al-Sadi R, Guo S, Dokladny K, Smith MA, Ye D, Kaza A, Watterson DM, Ma TY. Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo.J Interferon Cytokine Res. 2012;32:474-484.
[PubMed] [DOI]